Author |
Topic Search Topic Options
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Topic: TNBC Vaccine on the horizon Posted: Oct 12 2019 at 7:27am |
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 12 2019 at 1:08pm |
[“We’re also working on one to prevent cancer with the National Breast Cancer Coalition,” Knutson said. “We expect that to be in phase 1 clinical trials in 2020.”] This study is not yet listed and usually phase 1 is conducted with a very small population before they can move to phase 2 status. It usually takes many years to move from phase 1 status to public availability.
Here are the current Mayo Clinical vaccine clinical trials:
Here are the TNBC vaccine clinical trials:
Here are all the breast cancer vaccine clinical trials:
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 12 2019 at 4:58pm |
I5 almost sounds too good to be true..... but those timeframes are so long. The other thing is that they dont always pass clinical trials.
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 13 2019 at 12:53pm |
I agree. It can take well over a decade for a clinical trial to move through the process and many will not ultimately be approved. The clinical trial I participated in, a phase 3 open access, ultimately did not meet FDA approval.
This is from the ACS: "Clinical trials are only a small part of the research that goes into
developing a new treatment. Drugs of the future, for example, first have
to be discovered or created, purified, described, and tested in labs
(in cell and animal studies) before ever reaching human clinical trials.
Of all the substances that are tested in these early stages, very few
are promising enough to be tested in humans.
On average, a new cancer drug has been studied for at least 6 years
before it even makes it to clinical trials. But the major holdup in
making new cancer drugs available is how long it takes to complete
clinical trials themselves. It takes an average of about 8 years from
the time a cancer drug enters clinical trials until it’s approved.
Why so long? To be sure it’s safe and effective, researchers look at
each new treatment in several different studies. Only certain people are
eligible (meet the requirements) to take part in each clinical trial.
And cancer clinical trials take years to complete. It takes months, if
not years, to see if a cancer treatment works in any one person. And
figuring out if a drug really improves survival can take a very long
time."
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 28 2019 at 7:41am |
I read this article over the weekend and it helped remind me how many of the headlines we see about new treatments and cures may be over hyped.
Behind the Hype: Breast Cancer VaccineLast week my email burst forth with this headline: Florida woman recovers from breast cancer with trial vaccine
The article was about a woman named Lee Mercker who was
treated in a clinical trial at the Mayo Clinic in Jacksonville, Florida,
with an experimental breast cancer vaccine for women with early-stage
breast cancer. The article reported that the vaccine had gotten rid
of all of her cancer cells. Only later on do we read that she actually
also had a double mastectomy.
This type of hype is one of the problems with the breast
cancer news we often see, especially in October aka Breast Cancer
Awareness Month. It’s a shame because this research is really
important.
The researchers at the Mayo Clinic who are conducting this
study are supported in part by the Artemis Project of the National
Breast Cancer Coalition. They also are trying to develop a vaccine that
will prevent breast cancer. This type of work is complicated both
because the immune system, the human breast, and cancer are all very
complicated.
Previously, the vaccine had been studied only in mice.
This is the first time it is being studied in women. Early phase I
studies are designed to see if a treatment is safe and what effect it
has on cancer cells. The women enrolling in this trial are getting the
vaccine before surgery so that the researchers can see the effect it has
on their cancer cells. They are not receiving the vaccine as a breast
cancer treatment.
All the headlines I saw about this story would lead you to
believe that the vaccine cured her breast cancer. That is not what
happened. As the developer of the vaccine, Dr. Keith Knudson explained:
“We saw some evidence of elimination of the tumor, as well, as some
evidence of the immune system crowding in.” This does not mean the
treatment cured her cancer.
Now, the researchers will study the effect the vaccine has
in two other patients they have enrolled in this study. They also are
looking for more trial subjects. The fact that they saw an immune
response is great! But it is way too soon for that type of headline!
Susan Love, MD, MBA is the Chief Visionary Officer of the Dr. Susan Love Foundation for Breast Cancer Research.
https://rsusanloveresearch.org/behind-the-hype-breast-cancer-vaccine/
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|
sophie
Groupie
Joined: May 25 2019
Location: philadelphia
Status: Offline
Points: 69
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 29 2019 at 8:24am |
anyone is doing immunization therapy for prevention?
Also, when shall we start taking xeloda after chemo? My chemo is over close to 1.4 months, my doctor still asking me to wait to take ... why?
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 29 2019 at 4:34pm |
Is Xeloda after therapy established as best practice?
|
|
sophie
Groupie
Joined: May 25 2019
Location: philadelphia
Status: Offline
Points: 69
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 29 2019 at 7:57pm |
good question. What are you taking now? Have you completed chemo yet?
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 30 2019 at 1:46am |
No, still on Taxol/carboplatin. After that its radiation therapy, and that's all.
|
|
sophie
Groupie
Joined: May 25 2019
Location: philadelphia
Status: Offline
Points: 69
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 30 2019 at 7:15pm |
did you have sugery first?
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 31 2019 at 12:29am |
Yes Surgery first.
|
|
Kellyless
Senior Member
Joined: Jun 18 2009
Location: Dallas, Texas
Status: Offline
Points: 1154
|
Post Options
Thanks(0)
Quote Reply
Posted: Oct 31 2019 at 12:54pm |
Xeloda is mostly recommended for women that do neoadjuvant chemo and at surgery are found to have not obtained a PCR - they still have live cancer after chemo in their pathology. I've no idea how they ascertain if you should do it with surgery first. it's no small thing just because it's a pill and not IV, it comes with a list of side effects. Ask your medical oncologist for their opinion. You may also want to find out if your insurance will even pay for it if you had surgery first.
|
IDC, 2.2 cm, Stage IIb,lumpectomy 1/30/09 ACx4,Tx4 36 rads 6/1/16 Local recurrence same breast, same spot 1.8cm Carb.4x every 3 wks, Taxol 12x once wk. Dbl Mast. PCR!! Reconstruction fail, NED!
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Nov 12 2019 at 10:45pm |
Neoantigen DNA Vaccine
Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative
Breast Cancer Patients Following Standard of Care Therapy
Brief Summary:
This is a single institution,
open-label randomized phase 1 trial of neoantigen DNA vaccine alone vs.
neoantigen DNA vaccine plus durvalumab in triple negative breast cancer
(TNBC) patients following standard of care therapy. Patients with newly
diagnosed clinical stage II-III TNBC are eligible for enrollment.
Patients will receive standard of care therapy including chemotherapy,
surgery and radiation therapy as clinically indicated. Following
standard of care therapy, patients will be randomized to receive either a
neoantigen DNA vaccine alone, or a neoantigen DNA vaccine + durvalumab.
Condition or disease |
Intervention/treatment |
Phase |
Triple Negative Breast Cancer
Triple Negative Breast Neoplasms
TNBC - Triple-Negative Breast Cancer
Triple-negative Breast Carcinoma
|
Drug: Durvalumab
Biological: Neoantigen DNA vaccine
Device: TDS-IM system (Inchor Medical Systems)
Procedure: Peripheral blood draw
|
Phase
1
|
Edited by 123Donna - Nov 12 2019 at 10:47pm
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|